Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s):  N.MMED.WS | N.MMED.WA | N.MMED.WR | N.MMED

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).


NDAQ:MNMD - Post by User

Bullboard Posts
Comment by stanleyon Aug 16, 2011 11:15pm
461 Views
Post# 18950070

RE: :Zone 147 & Pecking Order & John Embry

RE: :Zone 147 & Pecking Order & John EmbryTerry:

[S] As we see the POG reach to higher heights and the U/G transition (increasing of stopes to 10/12 and new mining contractors).  The 26k appeared to be over optimistic. However margins in an increasing POG environment will minimize the downside of the production reduction.

A good mining engineer will only support/publish a figure that the quarterly mine plans & schedules gives ya. In my previous analysis/commentary on the YEP (year end projection). As the warrants get converted, there is revenue coming into the coffers.

The astute should pay close attention to Kerry's questions. He was looking for answers to the production rationalization. What is the new margin as we approach a sustained $1800 for POG. In a win-win situation an astute CEO will elect to get the development/stoping ratio to a level that can be sustained. i.e. No feast and famine and stuck waiting for development advance to produce properly sampled stopes for production. Using the water skiing example, do you want to see WD ski end to end or have many spills along the way?

Nice to hear Rick use the the word longhole, as it is indicative that he is looking to minimize the dilution. Higher grades increase recovery ultimately producing a lower cost per ounce. Ultimately surplus ounces can be held off the market until absolutely necessary. (a strategy used quite successfully by Goldcorp once their situation could support it).

Good call by WD on the consolidation.

Can we see the errors in the following NR?:

Lundin refreshes Brigus Gold buy

2011-08-16 20:40 AT - In the News

Brien Lundin, in the July,2011, edition of the Gold Newsletter, refreshes his buy of Brigus GoldCorp., recently $1.59. Mr. Lundin said buy in August, 2010, at $1.30 andin May, 2011, at $1.52.

Assuming a $1,000 investment for each buy, the$2,000 investment is now worth $2,267.

Brigus expects to produce atleast 16,500 ounces of gold in the second quarter and 26,000 ounces inthe third quarter, from its open-pit and underground operations at theBlack Fox mine in Timmins, Ont.

It is mining ore with grades of about6.2 grams per tonne gold (underground) and 3.4 g/t (from the open pit).At the underground mine, Brigus plans to increase the number of stopesto 10 or 12, from five, and hopes to raise the daily tonnage to 1,000tonnes per day, from 300 or 400. With gold prices over $1,500 an ounce,and the company's expected cash cost of less than $625 an ounce (byyear-end), Mr. Lundin says Brigus will be able to generate a decentamount of cash from its Black Fox operations. In the first quarter, thecompany produced 10,000 ounces of gold and earned $2.8-million.

The goldbug expects the stock price will increase when investors realize theiroversight of Brigus. He says this may happen in early fall.

Bullboard Posts